Researchers from Queen Mary University of London have uncovered a previously unknown mechanism by which HIV-1 can infect resting immune cells. The discovery challenges a decades-old assumption in HIV ...

Advancements in HIV/AIDS research, drug development and clinical practice since the 1980s have made it possible for people living with HIV to lead long, productive lives and keep the virus in check at ...

The human immunodeficiency virus (HIV), which is the cause of AIDS, is a master of deception, using just nine genes to hijack the complex cellular machinery of the human body. Yet, even after decades ...

Advancements in HIV/AIDS research, drug development, and clinical practice since the 1980s have made it possible for people living with HIV to lead long, productive lives and keep the virus in check ...

Doctors at San Francisco General Hospital's famed AIDS clinic have shown the immune system can be primed to keep the virus in ...

For 25 years, researchers have engineered immune cells to hunt down HIV. The approach, known as chimeric antigen receptor (CAR) T-cell therapy, extracts a patient’s T cells, engineers them to ...

For people living with HIV, the road to a promising cancer treatment can be longer than it should be, literally.

Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given. HARARE, ZIMBABWE, ROME, ITALY, NEW YORK, NY, AND CAMBRIDGE, MA / ACCESS ...

Jonathan Z. Li is at the Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. Read the paper: CD8+ T cell stemness precedes post-intervention control of HIV viremia ...

Paul Rubinstein, MD, discussed how cooperative groups are expanding CAR T and bispecific antibody research for patients with ...

Scientists in the Marson Lab at Gladstone Institutes have opened a new door to understanding HIV by creating the first genetic roadmap of how the virus interacts with real human cells. The human ...